Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

XYNTHA® Lyophilized Powder (antihemophilic factor [Recombinant])

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

XYNTHA® Lyophilized Powder Quick Finder

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the...
Did you find an answer to your question? Yes No

1 INDICATIONS AND USAGE

XYNTHA, Antihemophilic Factor (Recombinant), is indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:

  • On-demand treatment and control of...
Did you find an answer to your question? Yes No

2 DOSAGE AND ADMINISTRATION

For intravenous use after reconstitution only.

2.1 Dose

  • Dosage and duration of treatment depend on...
Did you find an answer to your question? Yes No

3 DOSAGE FORMS AND STRENGTHS

XYNTHA is available as a white to off-white lyophilized powder in the following nominal dosages:

  • 250 International Units
  • 500 International Units
  • 1000...
Did you find an answer to your question? Yes No

4 CONTRAINDICATIONS

XYNTHA is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster proteins.

...
Did you find an answer to your question? Yes No

5 WARNINGS AND PRECAUTIONS

5.1 Hypersensitivity Reactions

Allergic-type hypersensitivity reactions, including anaphylaxis, are possible with XYNTHA. Inform patients...

Did you find an answer to your question? Yes No

6 ADVERSE REACTIONS

The most common adverse reactions (≥10%) with XYNTHA in adult and pediatric previously treated patients (PTPs) were headache, arthralgia, pyrexia, and cough.

...
Did you find an answer to your question? Yes No

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Risk Summary

It is not known whether...

Did you find an answer to your question? Yes No

11 DESCRIPTION

The active ingredient in XYNTHA, Antihemophilic Factor (Recombinant), is a recombinant antihemophilic factor (rAHF), also called coagulation factor VIII, which is produced by recombinant DNA technology. It is...

Did you find an answer to your question? Yes No

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

XYNTHA temporarily replaces the missing clotting factor VIII that is needed for effective hemostasis.

...
Did you find an answer to your question? Yes No

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

No studies have been conducted with XYNTHA to assess its mutagenic or carcinogenic...

Did you find an answer to your question? Yes No

14 CLINICAL STUDIES

Three completed multicenter, open-label studies support the analysis of safety and efficacy of XYNTHA in on-demand treatment and control of bleeding episodes and perioperative management, and routine...

Did you find an answer to your question? Yes No

15 REFERENCES

  1. Nilsson IM, Berntorp EE and Freiburghaus C. Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost. 1993;70(1):56–59.
  2. Hoyer LW. Hemophilia A....
Did you find an answer to your question? Yes No

16 HOW SUPPLIED/STORAGE AND HANDLING

How Supplied

Each XYNTHA Vial Kit contains: one prefilled diluent syringe containing 4 mL 0.9...

Did you find an answer to your question? Yes No

17 PATIENT COUNSELING INFORMATION

Advise patients to:

  • read the FDA-approved patient labeling (Patient Information and Instructions for Use).
  • report any adverse reactions or problems that concern them when...
Did you find an answer to your question? Yes No

Instructions for Use

XYNTHA® /ZIN-tha/
[Antihemophilic Factor (Recombinant)]

XYNTHA is supplied as a...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No

Resources

Pfizer Factor Savings Card
For questions regarding the Pfizer Factor Savings Card, please call 1-844-989-HEMO (4366)
Didn’t find what you were looking for? Contact us.
Report Adverse Event